WeVote

Bill

Bill

HB 40

Health care insurance; to eliminate cost-sharing for screening of men who are at high risk for prostate cancer

2026 Regular Session Introduced by Jeremy Gray

Alabama bill eliminates patient cost-sharing for prostate cancer screening in high-risk men to increase early detection rates and reduce financial barriers to preventive care.

Read for the Second Time and placed on the Calendar (Insurance)
0
WeVote Research Nonpartisan
Bill Summary · HB 40

Legislative bill overview

HB 40 would eliminate cost-sharing requirements (copayments, coinsurance, and deductibles) for prostate cancer screening tests in men identified as high-risk. The bill requires health insurance plans to cover these screenings at no out-of-pocket cost to the patient, similar to preventive care provisions already in federal health law for certain screenings.

Why is this important

Prostate cancer is the second-leading cancer diagnosis among U.S. men, with higher incidence and mortality rates in African American men. By removing financial barriers to screening, the bill aims to increase early detection rates in high-risk populations, potentially improving health outcomes and reducing long-term treatment costs through earlier intervention.

Potential points of contention

  • Definition of "high-risk": The bill does not specify clinical criteria for determining which men qualify as high-risk, leaving interpretation to insurers or regulators and potentially creating implementation inconsistencies
  • Insurance cost burden: Eliminating cost-sharing increases insurer expenses, which may be passed to employers or other policyholders through higher premiums
  • Medical guideline alignment: Major organizations (ACS, AUA) recommend individualized screening decisions rather than universal screening for high-risk groups, raising questions about whether the bill's approach aligns with current evidence-based practice

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.